<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Chikungunya virus</italic> (CHIKV) (family 
 <italic>Togaviridae</italic>, genus 
 <italic>Alphavirus</italic>), is the causative agent of chikungunya fever. After first isolation of CHIKV in 1952 in present-day Tanzania, outbreaks and epidemics were limited to regions of Asia, Africa, and the Pacific Islands. In 2013, CHIKV emerged for the first time in the Americas, with sustained autochthonous transmission and rapid spread through the region [
 <xref rid="pntd.0006505.ref001" ref-type="bibr">1</xref>â€“
 <xref rid="pntd.0006505.ref003" ref-type="bibr">3</xref>]. The acute symptoms of CHIKV infection are similar to those of infection with other arbovirus species, including 
 <italic>Dengue virus</italic> (DENV), 
 <italic>Zika virus</italic> (ZIKV), and 
 <italic>Mayaro virus</italic> (MAYV), each presenting with a constellation of symptoms including fever, headache, and myalgias/arthralgias. Long-term, CHIKV infections have been linked with persistent arthralgias in a subset of cases[
 <xref rid="pntd.0006505.ref003" ref-type="bibr">3</xref>]; it has also been reported that upwards of 90% of CHIKV-infected individuals are symptomatic, in contrast to findings with ZIKV, where it is estimated that only 20% of infected persons are symptomatic [
 <xref rid="pntd.0006505.ref004" ref-type="bibr">4</xref>,
 <xref rid="pntd.0006505.ref005" ref-type="bibr">5</xref>].
</p>
